These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2168536)

  • 1. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
    Tanaka A; Salem M; Eckroade RJ; Fujita DJ
    Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
    Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
    Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell division is required for expression of v-myc transforming properties in chicken embryonic neuroretina cells.
    Bechade C; Calothy G
    Oncogene; 1991 Dec; 6(12):2311-7. PubMed ID: 1662792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. v-Src-induced degradation of focal adhesion kinase during morphological transformation of chicken embryo fibroblasts.
    Fincham VJ; Wyke JA; Frame MC
    Oncogene; 1995 Jun; 10(11):2247-52. PubMed ID: 7784071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src.
    Lau AF
    Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of metalloproteinase (gelatinase) activity secreted from Rous sarcoma virus-infected cells correlates with transforming activity of src.
    Hamaguchi M; Yamagata S; Thant AA; Xiao H; Iwata H; Mazaki T; Hanafusa H
    Oncogene; 1995 Mar; 10(6):1037-43. PubMed ID: 7535415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of the transforming protein of Rous sarcoma virus with two cellular phosphoproteins.
    Brugge JS; Darrow D; Lipsich LA; Yonemoto W
    Prog Clin Biol Res; 1983; 119():135-47. PubMed ID: 6191339
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential tyrosine-specific phosphorylation of integrin in Rous sarcoma virus transformed cells with differing transformed phenotypes.
    Horvath AR; Elmore MA; Kellie S
    Oncogene; 1990 Sep; 5(9):1349-57. PubMed ID: 1699197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic activity and transformation potential of v-Src require arginine 385 in the substrate binding pocket.
    Senften M; Schenker G; Sowadski JM; Ballmer-Hofer K
    Oncogene; 1995 Jan; 10(1):199-203. PubMed ID: 7529917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional motifs of the Rous sarcoma virus src protein.
    Parsons JT; Wilkerson V; Parsons SJ
    Gene Amplif Anal; 1986; 4():1-19. PubMed ID: 2851527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
    Jong SM; Zong CS; Dorai T; Wang LH
    J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of host-dependent src kinase activity by co-expression with a heterologous tyrosine kinase.
    Liebl EC; England LJ; Martin GS
    Virology; 1993 Jul; 195(1):265-7. PubMed ID: 8317103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rous sarcoma virus does not induce sarcoma in early chick embryos by lack of the v-src gene expression.
    Ogura H; Fujiwara T; Tanaka T
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):477-82. PubMed ID: 1336425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activity of c-Src and Csk in fibroblasts transformed by v-src oncogene.
    Tuhácková Z; Vojtechová M; Hlavácek J; Ruzzene M; Sovová V; Pinna LA
    Biochem Biophys Res Commun; 2002 Jan; 290(2):790-5. PubMed ID: 11785970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between c-src tyrosine kinase activity and the control of glucose transporter gene expression.
    Matsouka PT; Flier JS
    Mol Endocrinol; 1989 Nov; 3(11):1845-51. PubMed ID: 2481817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.